The Effects of Vitamin D Supplements on Sports Performance of Female Indoor Elite Athletes
RCT
1 other identifier
interventional
37
1 country
1
Brief Summary
This study is a randomized, double-blind study evaluated the effects of 90 days of vitamin D supplementation, with or without calcium, on bone mineral density and sports performance in indoor female semiprofessional athletes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 22, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedFirst Submitted
Initial submission to the registry
July 22, 2026
CompletedFirst Posted
Study publicly available on registry
August 6, 2026
CompletedAugust 6, 2026
July 1, 2026
1 year
July 22, 2026
August 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
isokinetic muscle strength Biodex
Using the Biodex System 4 QuickSet, the players performed the maximum extension and flexion muscle strength test of the knee joints at 60∘ per second and 180∘ per second angular velocities. The action range is from 90∘ to 0∘. The maximum eccentric contraction was repeated five times, and the sequence was from slow to high angular velocity
From enrollment to the end post-test at 90 days.
Star excursion balance test
The players stood in the center of the star with bare feet. With their hands placed firmly on their hips, the left foot stood at the center point to control their balance while the right foot was used as a reaching foot, directing their positions onto another point. They must extend the right foot as far as possible in a straight line, lightly touch with their toes at the farthest distance, and then return to the center point and rest for two to five seconds. They have to repeat this step eight times in a clockwise direction, and then repeat this same test by changing the sides of their foot counterclockwise direction in a sequence. Finally, the testers recorded the length of each direction (with a minimum unit of 0.5 cm), and recorded the best distance for subsequent analysis. This test was done three times. The scale is reach distance (CM). Minimum is 0CM, and there is no fixed macimum. If greater reach distance is achieved, that means better dynamic balance.
From enrollment to the end post-test at 90 days.
Vertical jump test
The players hold a piece of tape, standing on the sideway of the wall. They then have to squat down, swing their arms, and jump up vertically as high as possible, extending their legs and arms. The scale is jump height in cm. Minimum score is 0cm, and there is no fixed maximum. If higher jump is reached, that means they have a better lower-limb power.
From enrollment to the end post-test at 90 days.
T-shape agility test
The players ran back and forth on four T-shaped angular cones. They 17performed a total of three tests and were recorded for the best speed for the subsequent analysis. Lastly, on the sport performance test, a 20-meter sprint test was recorded. The players started to sprint when instructed from a static position on a basketball court. Players performed three times with the best time recorded for subsequent analysis. The scale is measured in times (sec), minimum is 0 sec and there is no fixed maximum. When lower time is achieved, that means they have better agility.
From the entrollment to post-test at 90 days.
Study Arms (3)
Vitamin D group
EXPERIMENTALParticipants received daily vitamin D of 5000 IU (125 μg) throughout the intervention period.
Vitamin D and Calcium group
ACTIVE COMPARATORParticipants received one calcium tablet (600mg) daily and daily vitamin D of 5000 IU (125 μg) throughout the intervention period.
Control Group
PLACEBO COMPARATORParticipants received a placebo which does not contain vitamin D (contains medium-chain fatty acid oil), and a calcium placebo throughout the intervention period.
Interventions
Participants received 12 oral drops of vitamin D3 (cholecalciferol), providing a total daily dose of 5,000 IU (125 μg).
Participants received 12 oral drops of vitamin D3 (cholecalciferol), providing a total daily dose of 5,000 IU (125 μg), together with one 600 mg calcium tablet taken orally once daily.
Participants received a placebo which does not contain vitamin D (contains medium-chain fatty acid oil), and a calcium placebo.
Eligibility Criteria
You may qualify if:
- Athletes in Taiwan's top corporate league or semi-professional league that has been training and competing indoors for a long time.
You may not qualify if:
- Under 20 years old
- Pregnant
- Being in vulnerable groups such as prisoners or mentally handicapped, disabled, etc.
- Had skeletal muscle-related injuries or surgeris
- Have kidney and/or liver disease, lipid malabsorption of calcium and vitamin
- Having organ stones
- Have taken supplments and/or calcium and/or vitamin D and/or other related health foods within two weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fu Jen Catholic University Hospital
New Taipei City, Taiwan
Related Publications (5)
Farrokhyar F, Sivakumar G, Savage K, Koziarz A, Jamshidi S, Ayeni OR, Peterson D, Bhandari M. Effects of Vitamin D Supplementation on Serum 25-Hydroxyvitamin D Concentrations and Physical Performance in Athletes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Sports Med. 2017 Nov;47(11):2323-2339. doi: 10.1007/s40279-017-0749-4.
PMID: 28577257BACKGROUNDHolick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab. 2012 Apr;97(4):1153-8. doi: 10.1210/jc.2011-2601. Epub 2012 Mar 22. No abstract available.
PMID: 22442274BACKGROUNDZhang R, Naughton DP. Vitamin D in health and disease: current perspectives. Nutr J. 2010 Dec 8;9:65. doi: 10.1186/1475-2891-9-65.
PMID: 21143872BACKGROUNDMorton JP, Iqbal Z, Drust B, Burgess D, Close GL, Brukner PD. Seasonal variation in vitamin D status in professional soccer players of the English Premier League. Appl Physiol Nutr Metab. 2012 Aug;37(4):798-802. doi: 10.1139/h2012-037. Epub 2012 May 4.
PMID: 22554144BACKGROUNDMaestro B, Davila N, Carranza MC, Calle C. Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol. 2003 Feb;84(2-3):223-30. doi: 10.1016/s0960-0760(03)00032-3.
PMID: 12711007BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Principal Investigator
Study Record Dates
First Submitted
July 22, 2026
First Posted
August 6, 2026
Study Start
July 22, 2021
Primary Completion
July 22, 2022
Study Completion
December 31, 2022
Last Updated
August 6, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because the informed consent obtained from participants and the study's ethics approval did not include provisions for sharing de-identified participant-level data outside the research team.